Collectively, these results indicated that targeted inhibition of HNF1A expression was a vital factor in the ability of triptolide to reverse ABCB1-mediated paclitaxel resistance in NSCLC cells. This evidence concerns the gene ABCB1 and non-small cell lung carcinoma.